Hytrin

In the US, Hytrin (terazosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia, High Blood Pressure and Hyperhidrosis.

US matches:

• Hytrin


• Hytrin capsules

UK matches:

• Hytrin BPH 10mg Tablets (SPC)
• Hytrin BPH 1mg Tablets (SPC)
• Hytrin BPH 2mg Tablets (SPC)
• Hytrin BPH 5mg Tablets (SPC)
• Hytrin Tablets 10mg (SPC)
• Hytrin Tablets 1mg (SPC)
• Hytrin Tablets 2mg (SPC)
• Hytrin Tablets 5mg (SPC)

Ingredient matches for Hytrin

Terazosin

Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Hytrin in the following countries:

• Antigua & Barbuda


• Aruba


• Australia


• Bahamas


• Bangladesh


• Barbados


• Belgium


• Bermuda


• Canada


• Cayman Islands


• Chile


• China


• Colombia


• Czech Republic


• Ecuador


• Greece


• Grenada


• Guyana


• Haiti


• Hong Kong


• Hungary


• India


• Indonesia


• Ireland


• Israel


• Jamaica


• Luxembourg


• Malaysia


• Malta


• Netherlands


• Netherlands Antilles


• New Zealand


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Saint Lucia


• Saint Vincent & The Grenadines


• Singapore


• Slovakia


• South Africa


• Sri Lanka


• Suriname


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• Turks & Caicos Islands


• United Kingdom


• United States


• Venezuela


• Virgin Islands (British)

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.